Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Zu
HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2
Cancer Research
Cancer Research
Oncology
Related publications
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin
Oncotarget
Oncology
Metabolic Consequences of HIF Silencing in a Triple Negative Human Breast Cancer Xenograft
Oncotarget
Oncology
Epigenetic Silencing of HIC1 Promotes Epithelial-Mesenchymal Transition and Drives Progression in Esophageal Squamous Cell Carcinoma
Oncotarget
Oncology
Triple-Negative Breast Cancer
HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells
PLoS ONE
Multidisciplinary
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
Silencing the Roadblocks to Effective Triple-Negative Breast Cancer Treatments by siRNA Nanoparticles
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes